About this trial
The purpose of this study is to compare two different screening tests for detecting dysphagia (difficulty swallowing) as well as the risk for aspiration (silent swallowing of liquids/solids into the lungs) in patients after an ischemic stroke (when a blood clot blocks or narrows an artery leading to the brain).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥ 18 years old
Patients admitted to Lynn Rehabilitation Center with an admitting diagnosis consistent with acute ischemic stroke within the past 1 month
Patients able to provide informed, written consent. If patients are not cognitively able to give informed consent, then consent will be obtained from patient proxy in person or over the phone
Able to read and comprehend verbal instruction in English and/or Spanish
Disqualifiers
Adults > 80 years old
Pregnant women
Prisoners
Those with a prior history of dysphagia
Trial design
Single group
Treatments tested in this trial
Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool)
Other interventionUpon 1-2 days of admission to inpatient rehabilitation, the MASA will be administered for approximately 20 minutes during initial speech language pathology evaluation. The MASA will be administered at bedside as a cognitive/speech language evaluation as well as oropharyngeal function examination.
Non-standardized clinical swallow evaluation
Other interventionParticipants will receive current standard of care for dysphagia screening and treatment.
Treatment groups
Trial outcomes
Primary outcomes
Dysphagia measured by MASA
The MASA is a 24-item clinical test that evaluates swallowing in the order in which swallowing phases occur. Each item is quantitatively scored using either a 5-point or 10-point score at the end of which a total score out of 200 is summed up. The MASA takes approximately 15-20 minutes to perform and can then be repeated during a patient's clinical course to monitor for recovery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.